The Impact of Glucagon-like Peptide-1 Receptor Agonists on Cardiovascular–Kidney–Metabolic Health in Romanian Patients with Type 2 Diabetes: A Retrospective Study. Here, GLP1R is linked to type 2 diabetes mellitus.